抑制BCL6:一种有希望的方法来防止由生殖中心驱动的合免疫反应
Rens Kraaijeveld1, Dennis A Hesselink1, Louisa Steines2
1Erasmus Medical Center (MC) Transplant Institute, Department of Internal Medicine, University Medical Center Rotterdam, Rotterdam, Netherlands.
Frontiers in immunology
|November 17, 2025
概括
准BCL6,免疫反应的关键蛋白质,显示了防止器官移植后抗体介导排斥的希望. BCL6 抑制剂可能会破坏有害的免疫反应,导致移植损失.
科学领域:
- 免疫学 免疫学 免疫学
- 移植免疫学 移植免疫学
- 分子医学是分子医学.
背景情况:
- 抗体介导排斥 (AMR) 是固体器官移植后晚期全移植损失的主要原因.
- 针对内皮细胞上不匹配的人类白细胞抗原 (HLA) 的捐赠者特异性抗体 (DSA) 是AMR的核心.
- 全能B细胞和毛囊T辅助细胞 (Tfh),都表达BCL6,驱动DSA的产生和长寿的血细胞的形成.
研究的目的:
- 在器官移植的背景下,审查BCL6影响Tfh和B细胞分化和生殖中心形成的机制.
- 探索向BCL6的疗法的潜力,作为一种免疫抑制策略,以防止移植体排斥.
主要方法:
- 对B细胞和Tfh细胞生物学中BCL6功能的现有文献的综述.
- 分析BCL6在生殖中心形成和血细胞分化中的作用.
- 讨论新开发的BCL6抑制化合物及其在移植中的潜在治疗应用.
主要成果:
- BCL6对于B细胞分化为产生抗体的血细胞以及Tfh细胞的存活和激活至关重要.
- 抑制BCL6会破坏生殖中心的B细胞功能和Tfh细胞活动.
- 阻断BCL6已经在B细胞淋巴瘤中显示出有效性,这表明了更广泛的免疫抑制潜力.
结论:
- 在器官移植后的AMR的基础上,BCL6在幽默合免疫反应中发挥着关键作用.
- 抑制BCL6的化合物代表了一种潜在的新疗法策略,以控制DSA的产生,并防止异位移植的排斥.
- 向BCL6可能为器官移植中的免疫抑制提供一个新的途径,缓解AMR并改善长期移植存活率.
相关概念视频
B Cell Activation and Differentiation
15.9K
The adaptive immune response, a sophisticated defense mechanism, relies on the activation and differentiation of B lymphocytes, or B cells. These processes enable our bodies to mount a tailored response against specific pathogens such as bacteria, free virus particles, toxins, and parasites.
When naive B cells encounter a specific antigen that can bind to the B cell receptor (BCR) on their surface, they undergo sensitization to respond to the antigen's presence. Sensitization begins with...
When naive B cells encounter a specific antigen that can bind to the B cell receptor (BCR) on their surface, they undergo sensitization to respond to the antigen's presence. Sensitization begins with...
15.9K
Cell-mediated Immune Responses
83.4K
Overview
83.4K
Special Features of Adaptive Immunity
2.9K
The adaptive immune system, a crucial component of the overall immune response, offers a highly specialized defense against pathogens. It involves specific cell types and features, enabling it to combat infections effectively and efficiently.
The primary cell types involved in adaptive immunity are T cells and B cells. Each type has a unique role in defending the body against pathogens. T cells are responsible for cell-mediated immunity. They identify and eliminate infected cells directly,...
The primary cell types involved in adaptive immunity are T cells and B cells. Each type has a unique role in defending the body against pathogens. T cells are responsible for cell-mediated immunity. They identify and eliminate infected cells directly,...
2.9K
T Cell Activation and Clonal Selection
14.6K
T cells are integral to our adaptive immune system, recognizing and effectively responding to foreign antigens. T cell activation and clonal selection are pivotal in orchestrating this immune response. This article elucidates these mechanisms, detailing the roles of cluster of differentiation (CD) markers, major histocompatibility complex (MHC) molecules, costimulatory signals, and the process of clonal selection.
Naive T cells that have not yet encountered an antigen express two primary CD...
Naive T cells that have not yet encountered an antigen express two primary CD...
14.6K
Cells of the Adaptive Immune Response
8.4K
The T and B lymphocytes of the adaptive immune system develop from common lymphoid progenitor cells in the bone marrow. These progenitors give rise to precursors that eventually develop into both T and B lymphocytes. As these precursors mature, they gain the ability to detect and respond to foreign antigens in the body, a process known as immunocompetence. Additionally, these precursors acquire self-tolerance, a process that ensures they do not react to self-antigens. This intricate system...
8.4K


